Valuation Techniques: Discounted Cash Flow, Earnings Quality, Measures of Value Added, and Real Options

APPENDIX 6B: STATISTICAL DATA: PHARMACEUTICAL INDUSTRY

TABLE 6B.1 U.S. Shipments of Pharmaceutical Preparations, 1989–1990 (dollar amounts in millions)

Source: Department of Commerce, as reported in “Healthcare: Basic Analysis,” Standard & Poor’s Industry Surveys (August 20, 1992), p. H18.

TABLE 6B.2 Product Line Sales and Profits for Major Pharmaceutical Companies, 1991 (millions of dollars)

Source: Company reports, as reported in “Healthcare,” Standard & Poor’s Industry Surveys, p. H18.

TABLE 6B.3 Foreign Sales by Major U.S. Drug Companies, 1989–1991 (dollar amounts in millions)

Source: “Healthcare,” Standard & Poor’s Industry Surveys, p. H22.

TABLE 6B.4 Research and Development Expenditures for Major Pharmaceutical Companies, 1989–1991 (dollar amounts in millions)

Source: “Healthcare,” Standard & Poor’s Industry Surveys, p. H24.

TABLE 6B.5 Biggest Gainers in the U.S. Prescription ...